tert-butyl 6-oxo-8-oxa-2,5-diazaspiro[3.5]nonane-2-carboxylate, 95.0%, 100mg

1-(4-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-5,6-dihydropyridin-1(2H)-yl)ethanone, 95.0%, 25g

2-AMINO-N-CYCLOPROPYLACETAMIDE HCL, 95.0%, 2.5g

beta-Methyl-gamma-octanolactone (mixture of isomers)>98.0%(GC)25mL

2-methyl-N-(4-pyridinylmethyl)-1-propanamine hydrochloride, 95.0%, 1g

2-[2-(pyridin-4-yl)pyrrolidin-1-yl]pyridine-3-carboxylic acid, 95.0%, 1g

[1-(6-Chloro-3-pyridyl)cyclobutyl]methanol, 95%, 100mg

2-cyclohexen-1-amine, 95.0%, 100mg

2-(2-Chlorobenzoyl)-4-methylpyridine, 97.0%, 1g

Tris[4-(5-phenylthiophen-2-yl)phenyl]amine>98.0%(HPLC)200mg

Ethyl 3-amino-2-nitrobenzoate, 95.0%, 5g

SPE Cartridges CHROMAFIX® Dry (Na2SO4), 0.8 ml, Medium, 50 Piece(s)

4-Benzylidene-2-methyl-1,2,3,4-tetrahydroacridine-9-carboxylic acid, 98%, 250mg